Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score-Reference-Cited by-同舟云学术

Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score

Published:2023-12 Issue: Volume: Page:
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Sun Li-Yang,Wang Nan-Ya,Diao Yong-Kang,Yan Cun-Lin,Fan Zhu-Ping,Wei Lian-Hua,Li Hui-Jun,Guan Ming-Cheng,Wang Ming-Da,Pawlik Timothy M,Lau Wan Yee,Shen Feng,Lv Guo-Yue,Yang Tian

Funder

Abbott Diagnostics

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. Hepatocellular carcinoma;Llovet;Nat Rev Dis Primers,2021

2. Epidemiology of hepatocellular carcinoma;McGlynn;Hepatology,2021

3. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang;Nat Rev Gastroenterol Hepatol,2019

4. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma;Oka;Hepatology,1994

5. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma;Lok;Gastroenterology,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials;Biomedicine & Pharmacotherapy;2024-10

2. Diagnostic performance comparisons of two commonly used multi-biomarker-based scores for detection of hepatocellular carcinoma in non-alcoholic fatty liver disease;iLIVER;2024-06